The Food and Drug Administration yesterday added the AustinP51 emergency-use system to its list of ventilator authorized for emergency use in health care settings to treat adults during the COVID-19 pandemic.

The device is a portable emergency use resuscitator designed to provide either continuous or intermittent ventilatory support for patients requiring mechanical ventilation through volume control.

The agency said the AustinP51 should only be used by professionals who are qualified and trained in the use of general ventilation equipment, or who are specifically trained on the AustinP51 system.

Related News Articles

Headline
President Biden today announced new actions to spur more vaccinations nationwide against COVID-19, due in part to the rise of the SARS-CoV-2 delta variant.…
Headline
The AHA today released new Spanish-language public service announcements and related content pieces to support vaccination efforts and complement previously…
Headline
AHA today urged the Centers for Medicare & Medicaid Services to make permanent COVID-19 waivers that removed regulatory barriers to better patient care,…
Headline
The Food and Drug Administration July 28 extended to six months the shelf life for Johnson & Johnson’s COVID-19 vaccine. The decision is based on data from…
Headline
The Provider Relief Fund Deadline Extension Act (S. 2493/H.R. 4735) was introduced yesterday in the Senate and House. The AHA-supported bill would allow…
Headline
The AHA yesterday joined the U.S. Chamber of Commerce and American Medical Association in urging the 11th Circuit Court of Appeals to void a district court…